Hilton Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.38M Buy
18,120
+330
+2% +$118K 0.48% 47
2025
Q4
$5.82M Buy
17,790
+241
+1% +$76.4K 0.44% 57
2025
Q3
$4.95M Sell
17,549
-1,510
-8% -$438K 0.4% 61
2025
Q2
$5.32M Sell
19,059
-125
-0.7% -$35.4K 0.42% 60
2025
Q1
$5.98M Buy
19,184
+243
+1% +$71.8K 0.51% 53
2024
Q4
$4.94M Sell
18,941
-2,586
-12% -$767K 0.43% 59
2024
Q3
$6.94M Buy
21,527
+466
+2% +$152K 0.54% 49
2024
Q2
$6.58M Buy
21,061
+966
+5% +$284K 0.56% 49
2024
Q1
$5.71M Buy
+20,095
New +$5.88M 0.51% 56

Other funds holding AMGN

Hilton Capital Management's AMGN Position: Q1 2026 in Review

Hilton Capital Management increased its Amgen (AMGN) stake by 1.9% in Q1 2026, buying an estimated $118K and bringing the position to 18,120 shares worth $6.38M. The position accounts for 0.48% of the portfolio, ranked #47.

Hilton Capital Management first reported a position in AMGN in Q1 2024 and has held it in 9 quarters since. The position peaked at $6.94M in Q3 2024. 3,127 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Hilton Capital Management held 18,120 shares of Amgen worth $6.38M as of Q1 2026.
  • Hilton Capital Management bought 330 Amgen shares in Q1 2026, an estimated $118K.
  • Amgen made up 0.48% of Hilton Capital Management's portfolio in Q1 2026, its #47 holding.
  • Hilton Capital Management first reported a position in Amgen in Q1 2024 and has held it in 9 quarters since.
  • Hilton Capital Management's Amgen position peaked at $6.94M in Q3 2024.
  • 3,127 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Hilton Capital Management's 13F filing for Q1 2026, filed 15 May 2026.